The novel therapy of the medication represents a exciting development in the handling of type 2 diabetes. Unlike existing therapies, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide311080.csublogs.com/49958169/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment